How do we think about biopharma annual planning differently? The analogy we will draw on is fitness trackers and apps—built for mindfulness and…

In the biopharma industry, the Target Product Profile (TPP) is a critical tool for guiding the development and commercialization of new drugs.

In the ever-evolving biopharma landscape, success hinges not just on innovation but also on a clear roadmap guiding clinical and commercial…

Reflecting on my career and the significant societal and technological shifts during those years, I see it as split between two generations, each…

At the core of every successful launch lies a meticulously crafted plan, a robust governance structure, and expert management of its execution.

In the not-so-distant past, physician prescribing data was essentially a commodity with limited breadth or depth for the purposes of drug development…

This past December, the FDA finalized its guidance on rare diseases with the publication Rare Diseases: Considerations for the Development of Drugs…

Commercializing a pharmaceutical asset in one country is hard enough. Doing it on a global scale, with multiple country differences, is exponentially…

I grew up in the Midwest — the middle child in a large family. We were each tagged with certain labels and expectations: the smart ones, the…

In this post-COVID era, our clients have experienced a culture shift — driven by remote work, digital transformation, accelerated innovation, and a…